A split, conditionally active mimetic of IL-2 reduces the toxicity of systemic cytokine therapy
2022 · Nature Biotechnology · 73 citations
https://doi.org/10.1038/s41587-022-01510-z
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
8
Papers
93
Citations
3
h-index
2
i10-index
Kevin Zhangxu is an academic researcher. The author has contributed to research in topics: Immune Cell Function and Interaction & CAR-T cell therapy research & T-cell and B-cell Immunology. The author has an h-index of 3, co-authored 7 publications.
ORCID: 0000-0002-7477-6691https://doi.org/10.1038/s41587-022-01510-z
https://doi.org/10.1002/pon.70119
Click to start Chat